UBS Group’s Medical Properties Trust MPT Stock Holding History
Bought
Maintained
Sold
Other funds holding MPT
UBS Group's MPT Position: Q3 2026 in Review
UBS Group increased its Medical Properties Trust (MPT) stake by 18% in Q3 2026, buying an estimated $2.43M and bringing the position to 3,720,059 shares worth $12.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3140.
UBS Group first reported a position in MPT in Q4 2014 and has held it in 48 quarters since. The position peaked at $43.4M in Q3 2022. 409 funds tracked by Wall St. Rank hold MPT as of Q3 2026.
- UBS Group held 3,720,059 shares of Medical Properties Trust worth $12.9M as of Q3 2026.
- UBS Group bought 578,027 Medical Properties Trust shares in Q3 2026, an estimated $2.43M.
- Medical Properties Trust made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #3140 holding.
- UBS Group first reported a position in Medical Properties Trust in Q4 2014 and has held it in 48 quarters since.
- UBS Group's Medical Properties Trust position peaked at $43.4M in Q3 2022.
- 409 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.